Capsugel announces expanded capabilities for clinical trial services and high-potency compounds at Edinburgh facility. New cleanroom, warehouse, and capabilities support the company’s pipeline for pharmaceutical projects using liquid-filled hard capsule technology. Capsugel, a Lonza company, announced expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products utilizing liquid-filled hard capsule (LFHC) technology,…
Lonza Completes $5.5B Acquisition of CDMO Capsugel
Lonza completes acquisition of Capsugel to create leading integrated solutions provider to the global pharma and consumer healthcare industries. Lonza announced that following the receipt of all required regulatory approvals, it has completed the acquisition of Capsugel S.A. from KKR for USD 5.5 billion in cash, including refinancing of existing Capsugel debt of approximately USD 2…
Capsugel Expands Late-Stage Inhalation Product Development Capabilities
Capsugel Announces Broad Commercial Availability of MAST System
Capsugel, a global provider of high-quality dosage forms and solutions, today announced the broad commercial availability of its Modular Automated Sampling Technology (MAST) system, which directly transfers samples from bioreactors to analytical devices while maintaining process sterility. This first-of-its-kind technology allows aseptic collection of accurate, representative samples that generate detailed process information in real-time. MAST represents the…
Lonza to Acquire Capsugel in $5.5B Deal; Expands CDMO Market Reach
Capsugel Unifies Four Acquisitions Under One Brand
Capsugel Investing in Enhanced Micronization Capacity and Capabilities
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced an expansion of its facility in Quakertown, PA, to meet increasing customer demand for its micronization services for both clinical and commercial manufacturing. The company will double the size of its current pilot-scale capacity for clinical trial quantities and increase the…
Capsugel Expands Micro-Dosing Services
Combining its proprietary Xcelodose® technology with best practices established at Xcelience, Capsugel offers unmatched micro-dosing capabilities in both North America and Europe. Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, announced that it is expanding its micro-dosing services offering for early-phase feasibility work. Capsugel’s offering combines its proprietary Xcelodose® Precision Powder…